Nirav Vora appointed Chief Financial Officer

Management Changes View source PDF Explain this filing

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹214.99

prior close

₹216.29

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+1.7% vs market

Pharmaceuticals peers, median of 152sector-0.6%+2.0% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.1

15m

-0.2

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4-0.3+1.7-0.6+2.0

Next day

-0.0-0.1+0.1-0.1+0.0

+2.7+0.6+2.1+0.6+2.1

+0.7+0.1+0.6-0.2+0.9

-1.4-1.1-0.4-0.8-0.6

+4.7-0.1+4.7-0.7+5.3

+2.1-0.1+2.2-0.6+2.7

15d

+2.3+2.1+0.3-0.1+2.4

-0.9+0.3-1.3-2.4+1.5

-7.3-6.3-1.1-6.0-1.3

-13.4-4.7-8.7-6.3-7.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved Nirav Niranjankumar Vora as Chief Financial Officer and Key Managerial Personnel, effective October 7, 2025, following recommendations from the nomination and remuneration and audit committees. He is a commerce graduate and chartered accountant with over 18 years of experience in finance, taxation and related laws.

Likely market impact

Adds an experienced finance leader; no direct effect on earnings, operations or capital was disclosed.